Clinical Trial Update: Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen [Phase 2]

View source ↗

Summary

Phase 2 results evaluate the efficacy and safety of a PIKA adjuvant-containing rabies vaccine given on an accelerated regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• PIKA Rabies Vaccine (PIKA adjuvant) (PIKA-adjuvanted rabies vaccine)

Snippet

Sponsor: Yisheng Biopharma (Singapore) Pte. Ltd. | Conditions: Rabies | Phase 2 | Status: COMPLETED